← Back to patent-cliff list
依非韦伦
Tier C — Watch / tradeEfavirenz
百时美施贵宝
Originator
1998
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：HIV-1 RT
Brand：Stocrin、Sustiva、施多宁
Indications (approved)：HIV感染
Regional status
US
临床一期
1997-10-01
EU
撤市
China
批准上市
2000-06-16
Japan
批准上市
2008-04-07
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Efavirenz?
Approved indications include: HIV感染.
When does the Efavirenz patent expire?
No public expiry year is available for Efavirenz yet; this page updates once verified.
How do I get a quote for Efavirenz intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25